INTERNATIONAL PATENT: INSTITUT REGIONAL DU CANCER DE MONTPELLIER, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE DE MONTPELLIER, REGEN LAB FRANCE SAS FILES APPLICATION FOR "METHOD FOR THE DIAGNOSIS OF A CANCER WITH CHROMATIN-BOUND MDM2"

GENEVA, May 12 -- INSTITUT REGIONAL DU CANCER DE MONTPELLIER (208, rue des ApothicairesF-34090 MONTPELLIER), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101 rue de TolbiacF-75013 PARIS), UNIVERSITE DE MONTPELLIER (163 Rue Auguste BroussonnetF-34090 MONTPELLIER), REGEN LAB FRANCE SAS (2 avenue de Laponie91940 LES ULIS) filed a patent application (PCT/EP2024/080966) for "METHOD FOR THE DIAGNOSIS OF A CANCER WITH CHROMATIN-BOUND MDM2" on Nov 01, 2024. With publication no. WO/2025/093756, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organizat...